Contact Us

Contact Us

Please contact us below with any questions

info@quadratech.co.uk

+44 (0)33 3321 2371

Side Contact
×
COVID-19 Rapid Antigen Lateral Flow Tests in Stock in UK and Available to Buy - Buy Now
quadratech Logo
{{ toggleHam ? 'CLOSE' : 'MENU' }}
Next Day & International Delivery
Competitive Pricing
Over 30 Years Experience
Based In The UK

Human Coronavirus NL63 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) (500µg) (Special Terms Apply*)

X

We're always working hard to give our customers as much information on products and the best price possible. If you need any assistance or would like a quote please contact us and we will be happy to help

Human Coronavirus NL63 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) (500µg) (Special Terms Apply*) (QTXAG-671-500) is Human coronavirus NL63 full-length spike glycoprotein is a recombinant HCoV-NL63 spike protein, with sheep Fc-tag. This antigen is manufactured in HEK293 cells, with greater than % purity.

Product Brand:
Product Code: QTXAG-671-500
Description

Human coronavirus NL63 full-length Spike protein expressed in HEK293 cells and purified from culture supernatant. Amino acids 714-721 were replaced by an 8 AA glycine-serine linker to prevent proteolytic cleavage of the protein into S1 and S2.

*Special Terms: Please see product specification details below and our Ordering page for details.

Product Specification
Specification Type
Specification Value
Product Range
Product Code
QTXAG-671-500
Product Name
Human Coronavirus NL63 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) (500µg) (Special Terms Apply*)
Product Category
Product Brand
Product Analyte or Application
Product Size
1 x 500 µg
Product Special Terms
Q-TOX Term 1: Shipped Frozen on Dry Ice. Additional Shipping Charge for Dry Ice Applies
Q-TOX Term 2: Minimum Order Volume of 1000µg on Orders Requiring Dry Ice Shipment
Product Storage
Long Term: -80°C or below
Short Term: -80°C or below

Our Accreditations

Cookie Consent

Cookies help us deliver our services. By using our services, you agree to our use of cookies.